Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marchex (MCHX) EBT (2016 - 2025)

Marchex (MCHX) has disclosed EBT for 16 consecutive years, with -$994000.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBT fell 23.33% to -$994000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.4 million, a 176.06% decrease, with the full-year FY2024 number at -$4.6 million, down 35230.77% from a year prior.
  • EBT was -$994000.0 for Q3 2025 at Marchex, down from $91000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.7 million in Q4 2023 to a low of -$5.3 million in Q1 2021.
  • A 5-year average of -$1.0 million and a median of -$1.5 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 291.53% in 2022, then soared 397.75% in 2023.
  • Marchex's EBT stood at -$1.8 million in 2021, then crashed by 63.93% to -$2.9 million in 2022, then skyrocketed by 397.75% to $8.7 million in 2023, then tumbled by 118.53% to -$1.6 million in 2024, then skyrocketed by 38.53% to -$994000.0 in 2025.
  • Per Business Quant, the three most recent readings for MCHX's EBT are -$994000.0 (Q3 2025), $91000.0 (Q2 2025), and -$1.9 million (Q1 2025).